FDA Enforcement Class II Terminated

CME America T-Syringe Pump - NeoThrive - Product Usage: infusion of medications or fluids requiring continuous or intermittent delivery at precisely-controlled infusion rates through clinically acceptable routes of administration, including intravenous, subcutaneous, percutaneous, intra-arterial, epidural, in close proximity to nerves, and into an intra-operative site (soft tissue/body cavity/surgical wound site).

Recall: Z-0526-2021 · Reported December 9, 2020

Enforcement

Recall Number
Z-0526-2021
Event ID
86047
Classification
Class II
Status
Terminated
Product Type
Devices
Firm
CME America, LLC
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
December 9, 2020
Initiation Date
July 30, 2020
Classification Date
December 3, 2020
Termination Date
March 8, 2022
Address
14998 W 6th Ave Ste 830, N/A, Golden, CO, 80401-5025, United States

Description

CME America T-Syringe Pump - NeoThrive - Product Usage: infusion of medications or fluids requiring continuous or intermittent delivery at precisely-controlled infusion rates through clinically acceptable routes of administration, including intravenous, subcutaneous, percutaneous, intra-arterial, epidural, in close proximity to nerves, and into an intra-operative site (soft tissue/body cavity/surgical wound site).

Reason

Multiple reasons: 1) Due to wear and tear of pump motor block mechanism - may cause under infusion situations without the pump alarm being generated. 2) Due to cracks, pump hardware may be damaged by fluid used during the cleaning process.

Code Info

Model NeoThrive - Part Number(s) 100-101PSL UDI Code: Retired prior to UDI

Distribution

Worldwide distribution - U.S. Nationwide distribution including in the states of AZ, AK, CA, CO, CT, FL, ID, IL, KS, LA, MA, MI, MO, MT, NC, NE, NV, Oh, OK, OR, PA, TN, TX, WA, and WI. The country of Canada.

Quantity

Total pumps = 4,182 (all models)